(Q36524739)

14 August 2017

1 reference

title

Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice (English)

1 reference

14 August 2017

Maureen P Howell

1

1 reference

PubMed ID

16814372

14 August 2017

Louis J Muglia

series ordinal

2

1 reference

PubMed ID

16814372

14 August 2017

language of work or name

1 reference

30 June 2006

1 reference

Frontiers in Neuroendocrinology

14 August 2017

1 reference

14 August 2017

27

1 reference

14 August 2017

3

1 reference

14 August 2017

275-284

1 reference

Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Cytokines, stress, and depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Rapid reversal of psychotic depression using mifepristone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Health consequences of intimate partner violence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The hypothalamo-pituitary-adrenal axis in major affective disorder: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The stress cascade and schizophrenia: etiology and onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Hypothalamic-pituitary-adrenal axis and bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The psychobiology of neglect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Brain corticosteroid receptor balance in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The glucocorticoid receptor as a potential target to reduce cocaine abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The HPA axis and cocaine reinforcement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

When do antidepressants worsen the course of bipolar disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Antidepressant-induced mania: an overview of current controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Affective illness and schizophrenia in families with multiple schizophrenic members: independent illnesses or variant gene(s)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Neurobiological basis of depression: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The effects of chronic medical conditions on work loss and work cutback.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Stress, adaptation, and disease. Allostasis and allostatic load

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Recent advances in the neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Genetic modification of corticosteroid receptor signalling: novel insights into pathophysiology and treatment strategies of human affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Getting closer to affective disorders: the role of CRH receptor systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

New directions in the development of antidepressants: the interface of neurobiology and psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Do antidepressants regulate how cortisol affects the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The central vasopressinergic system: examining the opportunities for psychiatric drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Hippocampal atrophy in recurrent major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

COMT: a common susceptibility gene in bipolar disorder and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The effect of stress on salivary cortisol in panic disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Endocrine disturbances in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Subregion- and cell type-restricted gene knockout in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Salivary, total plasma and plasma free cortisol in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Current status of cortisol findings in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Cortisol in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

The human glucocorticoid receptor: one gene, multiple proteins and diverse responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2006.05.001

10.1016/J.YFRNE.2006.05.001

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16814372